We have a great Parkinson's study going on right now and we are activing looking for new patients that may qualify.
It is a Phase 3, 12-Week, Double-Blind, Double Dummy, Placebo-And Active-Controlled Efficacy and Safety Study of Preladenant in Subjects with Moderate to Severe Parkinson's Disease (Phase 3: Protocol No. PO4938).
This research study is for patients diagnosed with Parkinson's disease at 30 years of age or older. Must be taking carbidopa-levodopa (Sinemet) and on a stable dose for 4 weeks. Must be experiencing "off" periods for at least 2 hours during the day. Cannot have had a pallidotomy or deep brain stimulation surgery for Parkinson's. This research study is approximately 4 months with about 9 office visits. This research study is evaluation the safety and effectiveness of an investigational drug which may reduce "off" periods. There is no cost to participate and the patient/caregiver participation is voluntary. There may be some reimbursement for time and travel available. Contact Clinical Trials, Inc. at 501-227-6179 to see if you or a loved one might qualify. For email inquiries, contact info@clinicaltrialsinc.com
Reminder: This is a multi-site study and our site is located in Little Rock, AR - so you would need to be able to travel to Little Rock for office visits.
For even more info visit: http://www.advancedparkinsonsstudy.com/
No comments:
Post a Comment